1-8 of 8
Maher Gandhi
Close
Save search
Follow your search
Access your saved searches in your account
Would you like to receive an alert when new items match your search?
Close Modal
Sort by
Journal Articles

FLIPI24: An Improved International Prognostic Model Developed on Early Events in Follicular Lymphoma

Matthew J. Maurer, Vit K Prochazka, Christopher R. Flowers, Lasse Hjort Jakobsen, Diego Villa, Caroline E. Weibull, Elliot J. Cahn, Alexandra Smith, Herve Ghesquieres, Robert Kridel, Maher Gandhi, Chan Y. Cheah, Eliza Hawkes, John F. Seymour, Ciara L. Freeman, Michael Roost Clausen, Björn E Wahlin, Jonathan W. Friedberg, Carla Casulo, Thomas M. Habermann, Yucai Wang, Loretta J. Nastoupil, Peter De Nully Brown, David Belada, Andrea Janíková, Heidi Mocikova, Tomáš Fürst, Richard Burack, Peter Martin, Jonathon B. Cohen, Izidore S. Lossos, Brad S. Kahl, Brian K. Link, Karin E. Smedby, Laurie H. Sehn, Marek Trneny, Tarec Christoffer Christoffer El-Galaly, James R. Cerhan
Journal: Blood
Blood (2022) 140 (Supplement 1): 2292–2295.
https://doi.org/10.1182/blood-2022-157194
Published: 2022
Journal Articles

Crebbp Mutations Are Associated with Shorter Time to Progression in Limited-Stage Follicular Lymphoma Treated with Radiation

Samantha A Hershenfeld, Victoria Shelton, Mehran Bakhtiari, Lourdes Calvente, Katherine Lajkosz, Keren Isaev, Anjali Silva, Ting Liu, Marianne Brodtkorb, Francesco Annibale d'Amore, Maja Ludvigsen, Charlotte Madsen, Stephen Hamilton-Dutoit, Maher Gandhi, Joshua W.D. Tobin, Tara Baetz, David LeBrun, Nathalie A. Johnson, Andrew J. Mungall, Michael Crump, Jan Delabie, Mary Gospodarowicz, David Hodgson, Michael Hong, Vishal Kukreti, John Kuruvilla, Anca Prica, Rosemarie Tremblay-Lemay, Richard Tsang, Robert Kridel
Journal: Blood
Blood (2022) 140 (Supplement 1): 3532–3533.
https://doi.org/10.1182/blood-2022-156571
Published: 2022
Journal Articles

Lenalidomide Consolidation Added to Rituximab Maintenance Therapy in Patients Remaining PET Positive after Treatment for Relapsed Follicular Lymphoma: Phase 2 Australasian Leukaemia & Lymphoma Group NHL26 Study

Judith Trotman, Peter Presgrave, Duncan P. Carradice, Douglas Stuart Lenton, Maher Gandhi, Tara Cochrane, Xavier Badoux, Gloria Nkhoma, Belinda Butcher, Michael Fulham, Anna Johnston
Journal: Blood
Blood (2021) 138 (Supplement 1): 2428.
https://doi.org/10.1182/blood-2021-146343
Published: 2021
Journal Articles

Event-Free and Overall Survival in over 6,000 Patients Treated with Frontline Immunochemotherapy for Follicular Lymphoma between 2002-2018: First Report from the International FLIPI24 Consortium

Matthew J. Maurer, Vit K Prochazka, Christopher R. Flowers, Lasse H. Jakobsen, Diego Villa, Caroline Weibull, Elliot J. Cahn, Herve Ghesquieres, Robert Kridel, Maher Gandhi, Chan Yoon Cheah, Eliza Hawkes, John F. Seymour, Ciara L. Freeman, Michael Roost Clausen, Björn Wahlin, Brian K. Link, Karin Ekstroem Smedby, Laurie H. Sehn, Marek Trněný, Tarec Christoffer El-Galaly, James R. Cerhan
Journal: Blood
Blood (2021) 138 (Supplement 1): 3527.
https://doi.org/10.1182/blood-2021-145883
Published: 2021
Journal Articles

The NLPHL Tumor Microenvironment Is Markedly Enriched in the Tigit and PD-1 Signalling Axes Compared to Classical Hodgkin Lymphoma

Jay Gunawardana, Muhammed B. Sabdia, Karolina Bednarska, Soi C. Law, Sandra Brosda, Hennes Tsang, Lilia Merida De Long, Andreea Zaharia, Justina Lee, Emily Jude, Eliza Hawkes, Karthik Nath, Clare Gould, Melinda Lea Burgess, Fiona Swain, Joshua W.D. Tobin, Colm Keane, Simone Birch, Dipti Talaulikar, Sanjiv Jain, Mohamed Shanavas, Cameron Snell, Maher Gandhi
Journal: Blood
Blood (2021) 138 (Supplement 1): 3513.
https://doi.org/10.1182/blood-2021-145840
Published: 2021
Journal Articles

A Multi-Centre, Single-Arm, Open-Label Study Evaluating the Safety and Efficacy of Fixed Dose Rituximab in Patients with Refractory, Relapsing or Chronic Idiopathic Thrombocytopenic Purpura (R-ITP1000 Study) and Exploring Rituximab Response with the FcGammaR3A Polymorphisms

Huyen Tran, MBBS, MSc, FRACP, FRCPA, Jamie P Nourse, PhD, Rod Lea, PhD, Timothy A. Brighton, FRCPA, FRACP, MB, BS, MS, Andrew Grigg, MBBS, FRACP, FRCPA, Simon McRae, BMedSc, MBBS, FRACP, FRCPA, Daniel Thurley, MA, MB, BCHIR, Dep. pharm. med, MRCP, FFPM, Maher Gandhi, PhD, FRACP, FRCPath, FRCP, John Catalano, MBBS FRACP FRCPA
Journal: Blood
Blood (2011) 118 (21): 1157.
https://doi.org/10.1182/blood.V118.21.1157.1157
Published: 2011
Journal Articles

Loss of Heterozygosity (LOH) of PTPRJ in Non-Hodgkin`s Lymphoma (NHL)

Carlos A Aya-Bonilla, MSc, PhD student, Michael R Green, PhD, Emily Camilleri, Hons, PhD Student, Paula Marlton, MBBS, Rod Lea, PhD, Maher Gandhi, PhD, FRACP, FRCPath, FRCP, Lyn R Griffiths, Hons, PhD
Journal: Blood
Blood (2011) 118 (21): 5231.
https://doi.org/10.1182/blood.V118.21.5231.5231
Published: 2011
Journal Articles

Immunosuppression (IST) Can Be Safely Ceased during Chemotherapy for PTLD in Renal Transplant Patients.

Peter Mollee, MBBS, Matthew Hourigan, MBBS, David Johnson, MBBS, Mark Jones, BSc, Nikki Isbel, MBBS, Carmel Hawley, MBBS, Paula Marlton, MBBS, Maher Gandhi, MBBS, Scott Campbell, MBBS, Devinder Gill, MBBS
Journal: Blood
Blood (2007) 110 (11): 1366.
https://doi.org/10.1182/blood.V110.11.1366.1366
Published: 2007